OPEN APP
Home / Companies / Dr. Reddy’s allowed to sell generic eszopiclone in US

Hyderabad: Drugmaker Dr. Reddy’s Laboratories Ltd on Wednesday said it got approval from the US Food and Drug Administration (FDA) to sell its version of anti-insomnia drug eszopiclone in the US. Eszopiclone tablets are sold under the brand name Lunesta by US drugmaker Sunovion Pharmaceuticals Inc.

Lunesta had US sales of around $887 million in the 12 months to January, Dr.Reddy’s said in a statement, quoting US healthcare information provider IMS Health.

Mylan Inc. and Glenmark too have been allowed to launch eszopiclone along with Dr.Reddy’s.

Shares of Dr. Reddy’s fell 1.48% to Rs2,539.35 a unit on BSE on Wednesday, while the benchmark Sensex declined 0.92% to 22,277.23 points.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Post your comment

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout